BiPar Sciences, a biopharmaceutical company seeking treatments for breast and ovarian cancers, was acquired by Sanofi Aventis. Prior the acquisition, Howry distilled BiPar’s key messages and created a brochure to attract the Sanofi team.

BiPar Sciences, a biopharmaceutical company seeking treatments for breast and ovarian cancers, was acquired by Sanofi Aventis. Prior the acquisition, Howry distilled BiPar’s key messages and created a brochure to attract the Sanofi team.